Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

GlaxoSmithKline Protocol Summaries: Firategrast
Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS.
Integrating Acupuncture Within a Wellness Intervention for Women With Multiple Sclerosis: A Feasibility Study.
National MS Society: Sylvia Lawry Physician Fellowships
Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
Quantifying the early stages of remyelination following cuprizone-induced demyelination.
In vitro and in vivo pharmacological models to assess demyelination and remyelination.
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial.
Episode 1 with Dr. Timothy Vollmer on maintaining brain health
Optical coherence tomography reflects brain atrophy in MS: A four year study.
Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination.
Management of worsening multiple sclerosis with mitoxantrone: a review.
Webinar: Solutions for Genome Editing: TALEN, CRISPR, & Safe Harbor Integration
Sex differences in autoimmune diseases.
Keystone Symposium: Gut Microbiota Modulation of Host Physiology: The Search for Mechanism
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex (SYNERGY)
Sex differences in autoimmune disease.
MRI identification of the rostral-caudal pattern of pathology within the corpus callosum in the cuprizone mouse model.
Episode 27 with Dr. Brenda Banwell on the new journal Multiple Sclerosis and Related Disorders
De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected.
Biogen Idec reports positive top-line results from Phase 2 anti-LINGO-1 trial in people with acute optic neuritis
TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.
Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study.
Teva Receives Positive Outcome in Europe for Three-Times-a-Week COPAXONE® (Glatiramer Acetate) 40 mg/ml for the Treatment of Relapsing Forms of Multiple Sclerosis (RMS)
Clinically isolated syndrome - Rethinking the diagnosis.

Pages